Bank of New York Mellon’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-601,414
| Closed | -$212K | – | 4391 |
|
|
2016
Q3 | $212K | Sell |
601,414
-47,902
| -7% | -$16.9K | ﹤0.01% | 3879 |
|
|
2016
Q2 | $303K | Buy |
649,316
+32,290
| +5% | +$15.1K | ﹤0.01% | 3741 |
|
|
2016
Q1 | $839K | Buy |
617,026
+53,624
| +10% | +$72.9K | ﹤0.01% | 3171 |
|
|
2015
Q4 | $828K | Sell |
563,402
-25,336
| -4% | -$37.2K | ﹤0.01% | 3275 |
|
|
2015
Q3 | $930K | Sell |
588,738
-90,602
| -13% | -$143K | ﹤0.01% | 3207 |
|
|
2015
Q2 | $1.16M | Buy |
679,340
+60,413
| +10% | +$103K | ﹤0.01% | 3252 |
|
|
2015
Q1 | $860K | Buy |
618,927
+60,007
| +11% | +$83.4K | ﹤0.01% | 3384 |
|
|
2014
Q4 | $845K | Sell |
558,920
-30,096
| -5% | -$45.5K | ﹤0.01% | 3400 |
|
|
2014
Q3 | $1.21M | Sell |
589,016
-22,188
| -4% | -$45.7K | ﹤0.01% | 3180 |
|
|
2014
Q2 | $1.87M | Buy |
611,204
+55,853
| +10% | +$171K | ﹤0.01% | 2938 |
|
|
2014
Q1 | $1.39M | Buy |
555,351
+29,293
| +6% | +$73.3K | ﹤0.01% | 3112 |
|
|
2013
Q4 | $2.61M | Buy |
526,058
+74,505
| +16% | +$370K | ﹤0.01% | 2716 |
|
|
2013
Q3 | $1.03M | Buy |
451,553
+49,446
| +12% | +$113K | ﹤0.01% | 3229 |
|
|
2013
Q2 | $892K | Buy |
+402,107
| New | +$892K | ﹤0.01% | 3244 |
|